BUPIVACAINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bupivacaine Hydrochloride, and what generic alternatives are available?
Bupivacaine Hydrochloride is a drug marketed by Aspiro, Civica, Eugia Pharma, Hikma Pharms, Hospira, Meitheal, Somerset, Steriscience Speclts, B Braun Medical Inc, Baxter Hlthcare Corp, Huons, and Intl Medicated. and is included in thirty-four NDAs.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BUPIVACAINE HYDROCHLORIDE?
- What are the global sales for BUPIVACAINE HYDROCHLORIDE?
- What is Average Wholesale Price for BUPIVACAINE HYDROCHLORIDE?
Summary for BUPIVACAINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 12 |
NDAs: | 34 |
Finished Product Suppliers / Packagers: | 18 |
Raw Ingredient (Bulk) Api Vendors: | 119 |
Clinical Trials: | 1,674 |
Patent Applications: | 753 |
DailyMed Link: | BUPIVACAINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for BUPIVACAINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yongtao Sun | Phase 4 |
Montefiore Medical Center | N/A |
University Hospital "Sestre Milosrdnice" | N/A |
Pharmacology for BUPIVACAINE HYDROCHLORIDE
Drug Class | Amide Local Anesthetic |
Physiological Effect | Local Anesthesia |